Search research articles
Contact Us
Filters
Showing results (621-630 of 1,211) with videos related to
Page
of 122
Sort By:
Circulation
|
June 22, 2005
Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction
Scott D Solomon, Hicham Skali, Nagesh S Anavekar, et al.
Journal of the American College of Cardiology
|
October 29, 2013
Lipoprotein(a) for risk assessment in patients with established coronary artery disease
Michelle L O'Donoghue, David A Morrow, Sotirios Tsimikas, et al.
Circulation. Heart Failure
|
November 9, 2020
Patient Characteristics, Clinical Outcomes, and Effect of Dapagliflozin in Relation to Duration of Heart Failure: Is It Ever Too Late to Start a New Therapy?
Su E Yeoh, Pooja Dewan, Pardeep S Jhund, et al.
European Journal of Heart Failure
|
June 8, 2021
Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the PARADIGM-HF trial
Ankeet S Bhatt, Muthiah Vaduganathan, Brian L Claggett, et al.
JACC. Heart Failure
|
October 5, 2019
Lung Ultrasound in Acute Heart Failure: Prevalence of Pulmonary Congestion and Short- and Long-Term Outcomes
Elke Platz, Ross T Campbell, Brian Claggett, et al.
European Journal of Heart Failure
|
August 27, 2023
Heart failure, chronic obstructive pulmonary disease and efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: Insights from DELIVER
Jawad H Butt, Henri Lu, Toru Kondo, et al.
International Journal of Cardiology
|
February 4, 2023
Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials
João Pedro Ferreira, John G Cleland, Nicolas Girerd, et al.
Circulation. Heart Failure
|
March 3, 2025
Impact of Multimorbidity on Mortality in Heart Failure With Mildly Reduced and Preserved Ejection Fraction
Mingming Yang, Toru Kondo, Pooja Dewan, et al.
European Journal of Heart Failure
|
August 21, 2014
Impaired left atrial function in heart failure with preserved ejection fraction
Angela B S Santos, Elisabeth Kraigher-Krainer, Deepak K Gupta, et al.
JAMA Cardiology
|
August 25, 2018
Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial
Peder Langeland Myhre, Muthiah Vaduganathan, Brian L Claggett, et al.
Page
of 122
Search research articles
Search
Showing results (621-630 of 1,211) with videos related to
Sort By:
Page
of 122
Circulation
|
June 22, 2005
Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction
Scott D Solomon, Hicham Skali, Nagesh S Anavekar, et al.
Journal of the American College of Cardiology
|
October 29, 2013
Lipoprotein(a) for risk assessment in patients with established coronary artery disease
Michelle L O'Donoghue, David A Morrow, Sotirios Tsimikas, et al.
Circulation. Heart Failure
|
November 9, 2020
Patient Characteristics, Clinical Outcomes, and Effect of Dapagliflozin in Relation to Duration of Heart Failure: Is It Ever Too Late to Start a New Therapy?
Su E Yeoh, Pooja Dewan, Pardeep S Jhund, et al.
European Journal of Heart Failure
|
June 8, 2021
Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the PARADIGM-HF trial
Ankeet S Bhatt, Muthiah Vaduganathan, Brian L Claggett, et al.
JACC. Heart Failure
|
October 5, 2019
Lung Ultrasound in Acute Heart Failure: Prevalence of Pulmonary Congestion and Short- and Long-Term Outcomes
Elke Platz, Ross T Campbell, Brian Claggett, et al.
European Journal of Heart Failure
|
August 27, 2023
Heart failure, chronic obstructive pulmonary disease and efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: Insights from DELIVER
Jawad H Butt, Henri Lu, Toru Kondo, et al.
International Journal of Cardiology
|
February 4, 2023
Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials
João Pedro Ferreira, John G Cleland, Nicolas Girerd, et al.
Circulation. Heart Failure
|
March 3, 2025
Impact of Multimorbidity on Mortality in Heart Failure With Mildly Reduced and Preserved Ejection Fraction
Mingming Yang, Toru Kondo, Pooja Dewan, et al.
European Journal of Heart Failure
|
August 21, 2014
Impaired left atrial function in heart failure with preserved ejection fraction
Angela B S Santos, Elisabeth Kraigher-Krainer, Deepak K Gupta, et al.
JAMA Cardiology
|
August 25, 2018
Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial
Peder Langeland Myhre, Muthiah Vaduganathan, Brian L Claggett, et al.
Page
of 122